Author: Paulina Czarnecka

The Global Innovation and New Technology Health Event showcases leading health tech from around the world and is accelerating innovation in an inspiring and creative environment.GIANT is the Global Innovation And New Technology event promoting accelerating innovation and commercial success. GIANT is an unmissable “innovation conference and dynamic trade exhibition”, showcasing leading health technologies from around the world.

The event allows to meet and build partnerships with companies ranging from startups to global large corporates and get exposure to leading industry press and media and being interviewed by professional film companies. The event is organized to host a suitable stand for every business and budget.

We are happy to be there. Great event,large networking and great plenary sessions.

It has been a great time seeing more than 3000 MedTech professionals gathering in Boston to talk about innovation, future of medical technologies, market challenges, regulatory paradigms, health economics, M&A trends around the industry as well as Patients’ perspective and showcasing TOP50 MedTech Innovator competition companies.
We are very happy that we could take part in this great event, had tens of meetings and discussions with people from all over the industry. Also we were invited to become an AdvaMed member together with our SDS Optic project. We will be honored to join this great ecosystem of around 400 greatest companies in MedTech industry, from small early stage startups to biggest global players in the industry. Very much looking forward to our first initiatives and actions.

We are happy and thrilled to announce that we have been chosen, as the only company from Poland, to participate in the executive Pre-IPO 5th edition of Euronext #TechShare Class 2019-2020. Mateusz Sagan, SDS Optic Chief Business Officer and Supervisory Board Member, will take part in 2 academic seminars in Rotterdam and Lisbon as well in 4 workshop sessions in Berlin moderated by Euronext and key institutional partners, incl. investment bankers, legal advisers and auditors.

#TechShare, launched in September 2015, is the only European programme dedicated to tech companies focused on the future IPO. With annual cohorts of fast‐growing European tech companies, the programme is an educational network designed to help these high‐potential businesses understand the role of capital markets and how they can help them reach the next stage of their growth. Last year, for the first time Euronext welcomed companies from outside its domestic markets, with participants from Germany, Italy, Spain and Switzerland. The 2019-2020 class has a broad diversity with participants from across Europe: 13 from Belgium, 35 from France, 23 from Germany, 6 from Ireland, 12 from Italy, 12 from the Netherlands, 7 from Portugal, 12 from Spain, 12 from Switzerland and exclusively one from Poland.

The 132 tech companies participating have convened at Rotterdam’s Erasmus Centre for Entrepreneurship on 20 and 21 September for an academic campus on capital markets and TechShare 2019/2020 Class Kick-Off.
Over the course of two days, top executives from companies in the life sciences, cleantech and TMT industries across Europe have been working with professors from the Rotterdam School of Management under the form of expert sessions and group workshops. Topics covered included the entrepreneurial mindset, leading growth, scaling beyong borders, attracting talents and managing ownership.
In addition, founder stories from Onno van de Stolpe, CEO of Galapagos and Brent Wissink, CFO of Takeaway.com have related their experience of the IPO process and how they used capital markets to grow their business internationally.

The eight-month training, from September 2019 to April 2020, is structured around three main complementary modules, before graduating from the programme in May 2020:
• Two academic campuses with leading business schools, Rotterdam School of Management and Nova School of Business and Economics in Lisbon next March 2020;
• Four workshop sessions in each country with expert partners about the IPO process, the legal perspective, IPO valuation, equity story, financial communication, corporate governance and postlisting life;
• Individual coaching with audit firms, lawyers and communications/investor relations specialists providing customised advice on a more bilateral basis.

“Taking part in the #TechShare Pre-IPO Programme is a key milestone for us at SDS Optic to learn all key aspects of becoming public company and bulding value to our shareholders. Based on key takeaways from the programme we will be able to prepare a long term IPO strategy and detailed action plan. The kickoff at Rotterdam’s Schoold of Management has been a great networking event, mindsetting experience and keynotes from CEO of Galapagos and CFO of Takeaway.com have been tremendous” – says Mateusz Sagan, Supervisory Board Member and participant in the programme.

SDS Optic, headquartered in Lublin, is a highly innovative growing biotech company, focused on development of novel diagnostic strategies in the field of oncology. Company develops and innovates diagnostics solutions, responding to needs of patients with cancer and focusing on helping the healthcare with faster and less painful diagnostics. Our Mission is „Saving, Monitoring and Improving Lives through Innovative Cancer Diagnostics Solutions”.

As part of our R&D expansion plan and SME Instrument Horizon 2020 project kick-off we’re currently expanding our biology group and looking for a highly motivated and talented scientist to work as:

BIOLOGY SENIOR SCIENTIST / TEAM LEADER

(based in Lublin, Poland)

Ref. No. SDS 01/06/LUB/19

Major Responsibilities:

• Leading Team of biologists and technicians focused on product development
• Working in the lab executing immunochemical and biochemical assays
• Managing work of associates to meet the company and project timelines
• Working within the interdisciplinary team
• Utilizing expert knowledge on cancer biology

Requirements:

• Accomplished Biologist, at least PhD level
• 2-4 years’ experience for the Sr. Scientist role or 5 years’ experience as a Group Leader position
• Technical experience in the area of pre-clinical and clinical diagnostic research is essential for this position
• Highly energetic with hands-on experience in development and validation of in vitro assays aimed to verify target binding
• Training and/or experience in basic molecular biology techniques like cell culture, cytotoxicity and proliferation assays, Western blot and ELISA, protein based in vitro activity assays is a must
• You have to show ability to carry out high quality science and demonstrate a high level of initiative and independence in performing experiments
• Strong leadership, interpersonal and communication skills to be capable of being a Team Leader in diagnostics development projects
• We expect from You to be flexible, multitasking and feel comfortable working in goal driven diagnostics discovery environment
• Fluent in English and familiar with computer general office applications

What we offer:

• Working in a highly innovative, self-driven and growing biotech startup, executing SME Instrument project co-financed by European Commission
  Competitive package and great atmosphere
• Everyone wishing to join us feel free to send your resume at praca@sdsoptic.pl marking with Ref. No. SDS/01/06/LUB/19. Please add personal data protection clause if you wish to be considered.
• We will get in touch only with chosen candidates.

Good Luck and we’re looking forward to seeing YOU as part of our growing TEAM.

The Florida International Medical Expo is the largest medical trade fair across the Americas which will bring together medical and healthcare trade professionals from North, Central and South America, as well as from across the globe, to do business with national and international companies exhibiting new and refurbished medical and hospital equipment, technology, products and supplies. This year event took place in Miami Beach. We’ve represented Poland at Polish National Stand. It was great opportunity to meet new people and talk more about our breakthrough innovation inPROBE.
Thank you all for visiting our booth and all discussions we had. Here are the highlights for all days at FIME.

We had privilage and honour to be be invited by Roche to Basel HQ and take part in Partnering for Innovation Summit. Around 500 top Roche Executives and carefully selected 40 startups, among them us presenting our disruptive inPROBE technology as the only startup from CentralEurope, came together to talk about Driving Healthcare into the Future.
Several great presentations, keyonte speaks on innovation, round tables, workshops, SDSOptic brand table, Mateusz Sagan pitching and talking about inPROBE and our Co-Founders Magdalena Staniszewska and Marcin Staniszewski speaking to many Roche Team Members.

Key take aways from the summit:
– the future is around Value Based Healthcare
– Point-of-Care targeted Diagnostics is key – in confront with several innovative targeted treatments
– Managing Patients data in one place
– AI & Blockchain has widely arrived to Healthcare
– AI is not going to replace Doctors. AI+Doctors will replace Doctors
Happy to be here, thank you #Roche for having us in Basel, key notes taken and we go back to work hard to deliver on our inPROBE promises